Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03982992
Brief Title: Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab (DLI-TARGET)

First Submitted : June 3, 2019
First Submitted that Met QC Criteria : June 8, 2019
First Posted : June 12, 2019

Last Update Submitted that Met QC Criteria : June 13, 2019
Last Update Posted : June 14, 2019